Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
Total Renal Care Reports 2nd Quarter Results
DaVita (Total Renal Care Holdings, Inc.) , today announced results for the quarter ended June 30, 2000. Net earnings after tax were $2.3 million, or $0.03 per share, excluding previously announced…
-
Total Renal Care Announces Settlement of Securities Class Actions
DaVita (Total Renal Care Holdings, Inc.) (NYSE: TRL) announced today that it has signed a Stipulation of Settlement with the plaintiffs in the consolidated securities class actions that were filed…
-
Total Renal Care Announces Restructuring of Senior Credit Facilities
DaVita (Total Renal Care Holdings, Inc.) (NYSE: TRL) announced today that it has completed a restructuring of its revolving and term loan credit facilities. “This constitutes another significant…
-
Total Renal Care Announces New Company Name
Total Renal Care Holdings, Inc. (NYSE: TRL), today announced that it will be changing its name to DaVita. “Because we are a new Company in many, many respects, our team wanted to give their…
-
Total Renal Care Announces Executive Appointments
Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 TORRANCE, California, May 16, 2000—Total Renal Care Holdings, Inc. (NYSE: TRL), announces the following…